<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1562">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 10, 2022</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01434940</url>
  </required_header>
  <id_info>
    <org_study_id>N/2009/55</org_study_id>
    <nct_id>NCT01434940</nct_id>
  </id_info>
  <brief_title>Eye Movement Recording as an Early Differential Diagnostic Tool for Alzheimer/Depression</brief_title>
  <acronym>MOMAD</acronym>
  <official_title>Early Oculomotor Markers in Alzheimer's Disease: Test of Predictive Value in the Differential Diagnosis Depression/Alzheimer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Besancon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Laboratoire de psychologie EA 3188</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Centre Hospitalier Universitaire Dijon</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Centre Hospitalier de Novillars</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Besancon</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The global aim of our study is to validate eye movement recording as an early differential&#xD;
      diagnostic tool, in order to discriminate as early as possible between neurodegenerative&#xD;
      dementias of Alzheimer type and depressive pseudodementias (DPD). The investigators want to&#xD;
      put forward idiosyncratic oculomotor characteristics of Alzheimer's disease (AD) and DPD&#xD;
      respectively. Eye movements are sensitive markers of neurological diseases and can be used in&#xD;
      a variety of clinical neurological syndromes.&#xD;
&#xD;
      This study compares 3 groups of 98 patients: patients suffering of AD and DPD and healthy&#xD;
      persons. The patients AD will be recruited in the Memory Centre of Resources and Research of&#xD;
      Besançon and patients DPD will be selected in the psychiatric department of the University&#xD;
      Hospital of Besançon. The control participants will be recruited from the entourage of&#xD;
      researchers and patients. The selection of participants in the 3 different groups is based on&#xD;
      clinical examinations in psychiatry and neurology and neuropsychological assessments. After&#xD;
      giving informed consent, patients will be evaluated by a psychiatrist and a&#xD;
      neuropsychologist. The complete assessment takes 150 minutes.&#xD;
&#xD;
      After having set up patients, eye movements will be recorded using video-oculography&#xD;
      techniques. The following tasks are performed: the basic dynamic eye movements (latency,&#xD;
      hypometric and hypermetric saccades, reaction time, saccade speed, accuracy, pupil diameter)&#xD;
      will be evaluated by the pro-saccade, anti-saccade and predictive saccade tasks. The&#xD;
      emotional connotation tasks will be assessed by scan of images pair with emotional&#xD;
      connotation and portrait analysis. The assessment takes 30 minutes.&#xD;
&#xD;
      This study will include 3 groups:&#xD;
&#xD;
        -  an Alzheimer group;&#xD;
&#xD;
        -  a depressed group;&#xD;
&#xD;
        -  a control group with healthy persons. The population of this study will be comprised of&#xD;
           patients over age 60 with a visual acuity over 9/10, not diagnosed with eye disease and&#xD;
           not neuropsychological sequelae that could disrupt the functioning oculomotor.&#xD;
&#xD;
      These people will be recruited on a voluntary basis, after notification and consent in the&#xD;
      research center, the Psychiatry Clinical Department of the University Hospital of Besançon.&#xD;
      This study was conducted over a period of 36 months.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>April 2010</start_date>
  <completion_date type="Anticipated">July 2018</completion_date>
  <primary_completion_date type="Anticipated">January 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>pro-saccade task</measure>
    <time_frame>session1: after psychiatric and neuropsychologic assessment</time_frame>
    <description>The score differences to pro-saccade task between the 3 groups constitute the major research outcome measure used to measure the basic dynamic eye movements.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>anti-saccade task</measure>
    <time_frame>session 2: after session 1 (pro-saccade task)</time_frame>
    <description>The score differences to anti-saccade task between the 3 groups consitute one of the major research outcome measure used to measure the basic dynamic eye movements.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>predictive saccade task</measure>
    <time_frame>session 3: after session 2 (anti-saccade task)</time_frame>
    <description>The score differences to predictive saccade tasks between the 3 groups constitute one of the major research outcome measure used to measure the basic dynamic eye movements</description>
  </primary_outcome>
  <primary_outcome>
    <measure>scan of images pair with emotional connotation</measure>
    <time_frame>session 4 : after session 3 (predictive saccade task)</time_frame>
    <description>The score differences of scan of images pair with emotional connotation were used to evaluate the emotional tasks</description>
  </primary_outcome>
  <primary_outcome>
    <measure>portrait analysis</measure>
    <time_frame>session 5: after session 4 (scan of images pair with emotional connotation)</time_frame>
    <description>The score differences of portrait analysis were used to evaluate the emotional tasks</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">288</enrollment>
  <condition>Alzheimer Disease</condition>
  <condition>Depression</condition>
  <arm_group>
    <arm_group_label>Alzheimer</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients suffering of Alzheimer disease</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Depression</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients suffering from depression</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Healthy volunteers</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Eye movements will be recorded using video-oculography techniques based on both the corneal reflection principle and an infra-red light beam</intervention_name>
    <description>. The system named H6-HSCN by Applied Science Laboratories (ASL®) helps keep the patient's head fixed on a support, important for the elderly population. This system allows to capture data with good temporal resolution (sampling at 360Hz) and good spatial resolution (accuracy of 0.1° of visual angle) at a distance of about 70 cm from the screen test with a visual angle of 32.6°. Results will be processed with ASL Result Software.</description>
    <arm_group_label>Alzheimer</arm_group_label>
    <arm_group_label>Depression</arm_group_label>
    <arm_group_label>Healthy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  subject whose visual acuity &gt; 9/10&#xD;
&#xD;
          -  subject without a diagnosis of eye disease&#xD;
&#xD;
          -  subject without a neuropsychological sequelae&#xD;
&#xD;
          -  for depressed patients :subject with a diagnosis of depression confirmed by a&#xD;
             psychiatric evaluation and MADRS (Montgomery and Asberg Depression Rating Scale) score&#xD;
             &gt;25 and without cognitive impairment or any other psychiatric pathology and MMSE (Mini&#xD;
             Mental State Examination)≥18 and without symptoms of AD&#xD;
&#xD;
          -  for Alzheimer patients :subject with AD diagnosed according to NINCDS-ADRDA (National&#xD;
             Institute of Neurological and Communicative Disorders and Stroke -Alzheimer's Disease&#xD;
             and Related Disorders Association) criteria and MMSE ≥18 and without psychiatric&#xD;
             disorder and MADRS score &lt; 25&#xD;
&#xD;
          -  for control patients : subject without AD, depression or any other psychiatric&#xD;
             condition identified by the diagnostic criteria or cognitive disorders and MADRS score&#xD;
             &lt;25 and MMSE &gt; 20&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  subject age under 60&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pierre VANDEL, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Hospitalier Universitaire de Besancon</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Pierre VANDEL, Prof</last_name>
    <phone>+33381218073</phone>
    <email>pierre.vandel@univ-fcomte.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Univserity Hospital of Besançon - Psychiatry Department</name>
      <address>
        <city>Besançon</city>
        <zip>25000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julie MONNIN, PhD</last_name>
      <phone>+33381218543</phone>
      <email>jmonnin@chu-besancon.fr</email>
    </contact>
    <contact_backup>
      <last_name>Magali NICOLIER, PhD</last_name>
      <phone>+3381218073</phone>
      <email>mnicolier@chu-besancon.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Pierre VANDEL, PUPH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2017</verification_date>
  <study_first_submitted>September 14, 2011</study_first_submitted>
  <study_first_submitted_qc>September 14, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 15, 2011</study_first_posted>
  <last_update_submitted>July 27, 2017</last_update_submitted>
  <last_update_submitted_qc>July 27, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 31, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Alzheimer disease</keyword>
  <keyword>Depression</keyword>
  <keyword>Differential diagnosis</keyword>
  <keyword>Eye movement</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alzheimer Disease</mesh_term>
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

